CARGO THERAPEUTICS IN

CARGO Therapeutics to Participate in Upcoming Investor Conferences

05 11 2024 15:05:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity

05 11 2024 08:23:06 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

12 8 2024 15:05:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet

10 7 2024 07:00:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director

04 6 2024 15:05:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics to Participate in Upcoming Investor Conferences

28 5 2024 07:05:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing

28 5 2024 07:00:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

14 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors

15 4 2024 15:05:00 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

21 3 2024 15:05:47 提供 Nasdaq GlobeNewswire

CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference

29 2 2024 15:01:51 提供 Nasdaq GlobeNewswire

CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 07:05:03 提供 Nasdaq GlobeNewswire

CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results

13 12 2023 15:05:36 提供 Nasdaq GlobeNewswire